Here's the live share price of Molbio Diagnostics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Molbio Diagnostics | 2.93 | 24.96 | 24.96 | 24.96 | 24.96 | 7.70 | 4.55 |
| Apollo Hospitals Enterprise | -2.91 | -1.88 | 3.69 | 16.10 | 10.79 | 19.70 | 12.26 |
| Max Healthcare Institute | -0.79 | 2.45 | 0.45 | 6.01 | -11.23 | 21.35 | 20.41 |
| Manipal Health Enterprises | -3.77 | -2.67 | 5.36 | 5.36 | 5.36 | 1.72 | 1.03 |
| Fortis Healthcare | -4.19 | -3.99 | -9.83 | 8.04 | -9.68 | 38.95 | 26.18 |
| Aster DM Quality Care | -5.15 | -9.72 | -5.10 | 13.87 | 19.45 | 29.92 | 26.65 |
| Global Health | -5.29 | -0.89 | 13.44 | 34.65 | 3.05 | 26.24 | 27.52 |
| Narayana Hrudayalaya | -2.76 | 0.50 | -1.41 | 11.92 | 2.87 | 18.74 | 27.89 |
| Krishna Institute of Medical Sciences | -0.75 | -5.18 | -2.45 | 17.55 | 0.38 | 23.96 | 24.93 |
| Dr. Lal Pathlabs | -1.34 | 0.98 | 15.43 | 41.28 | 15.74 | 17.17 | -1.49 |
| Dr. Agarwals Health Care | -2.92 | -0.18 | 13.84 | 18.31 | 13.47 | 7.53 | 4.45 |
| Vijaya Diagnostic Centre | -3.73 | -4.32 | 11.02 | 53.82 | 37.07 | 43.96 | 17.50 |
| Rainbow Childrens Medicare | 0.47 | -1.12 | 2.51 | 31.09 | 0.26 | 12.58 | 26.49 |
| Park Medi World | -0.73 | 1.14 | 3.54 | 50.90 | 88.80 | 23.70 | 13.61 |
| Metropolis Healthcare | -3.25 | 5.53 | 9.06 | 26.57 | 12.31 | 15.89 | -6.14 |
| Healthcare Global Enterprises | -5.05 | -5.03 | 8.00 | 22.83 | 0.66 | 23.64 | 23.07 |
| Yatharth Hospital & Trauma Care Services | -1.29 | 15.87 | 18.06 | 50.17 | 24.62 | 36.94 | 23.95 |
| Jupiter Life Line Hospitals | -3.05 | -12.77 | 2.61 | 8.17 | -5.12 | 8.57 | 5.06 |
| Thyrocare Technologies | -4.67 | -12.48 | 1.50 | 50.14 | 36.09 | 40.48 | 4.97 |
| Nephrocare Health Services | -0.71 | 4.90 | -1.97 | 37.97 | 54.36 | 15.57 | 9.07 |
Source: Dion Global
Over the last one year, Molbio Diagnostics has gained 24.96% compared to peers like Apollo Hospitals Enterprise (10.79%), Max Healthcare Institute (-11.23%), Manipal Health Enterprises (5.36%). From a 5 year perspective, Molbio Diagnostics has underperformed peers relative to Apollo Hospitals Enterprise (12.26%) and Max Healthcare Institute (20.41%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,235.66 | 1,336.18 |
| 10 | 1,166.11 | 1,254.18 |
| 20 | 1,089.97 | 1,162.05 |
| 50 | 435.99 | 0 |
| 100 | 217.99 | 0 |
| 200 | 109 | 0 |
Source: Dion Global
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 18,441 | 0.05 | 1.49 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Sep 12, 2026, 03:45 PM IST IST | Molbio Diagnostics - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Sep 09, 2026, 05:47 AM IST IST | Molbio Diagnostics - Change Of Corporate Identification Number (CIN) Of The Company. |
| Sep 08, 2026, 11:47 PM IST IST | Molbio Diagnostics - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Sep 08, 2026, 08:28 PM IST IST | Molbio Diagnostics - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Sep 07, 2026, 03:23 PM IST IST | Molbio Diagnostics - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Source: Dion Global
Molbio Diagnostics Ltd. is a Public Limited Listed company incorporated on 20/10/2000 and has its registered office in the State of Goa, India. Company's Corporate Identification Number(CIN) is U33125GA2000PLC002909 and registration number is 002909. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 1313.40 Cr. and Equity Capital is Rs. 11.28 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Molbio Diagnostics is ₹1,297.20 as on Sep 16, 2026.
The Molbio Diagnostics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Molbio Diagnostics is ₹14,957.58 Cr as on Sep 16, 2026.
Today’s highest and lowest price of Molbio Diagnostics are ₹1,438.70 and ₹1,198.60.
The 52-week high/low is the highest and lowest price at which Molbio Diagnostics stock has traded in the past 52-week or nearly a year. The 52-week high of Molbio Diagnostics is ₹1,686.50 and 52-week low of Molbio Diagnostics is ₹925.80 as on Sep 16, 2026.
The Molbio Diagnostics has shown returns of -5.56% over the past day, 24.07% for the past month, 24.07% over 3 months, 24.07% over 1 year, 7.56% across 3 years, and 4.47% over 5 years.
P/E ratio of and PB ratio of Molbio Diagnostics are 0.00 and 12.79 on Sep 16, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global